177 related articles for article (PubMed ID: 34226527)
1. The AML-associated K313 mutation enhances C/EBPα activity by leading to C/EBPα overexpression.
Gentle IE; Moelter I; Badr MT; Döhner K; Lübbert M; Häcker G
Cell Death Dis; 2021 Jul; 12(7):675. PubMed ID: 34226527
[TBL] [Abstract][Full Text] [Related]
2. C/EBPγ deregulation results in differentiation arrest in acute myeloid leukemia.
Alberich-Jordà M; Wouters B; Balastik M; Shapiro-Koss C; Zhang H; Di Ruscio A; Radomska HS; Ebralidze AK; Amabile G; Ye M; Zhang J; Lowers I; Avellino R; Melnick A; Figueroa ME; Valk PJ; Delwel R; Tenen DG
J Clin Invest; 2012 Dec; 122(12):4490-504. PubMed ID: 23160200
[TBL] [Abstract][Full Text] [Related]
3. Identification of gene targets of mutant C/EBPα reveals a critical role for MSI2 in CEBPA-mutated AML.
Heyes E; Schmidt L; Manhart G; Eder T; Proietti L; Grebien F
Leukemia; 2021 Sep; 35(9):2526-2538. PubMed ID: 33623142
[TBL] [Abstract][Full Text] [Related]
4. Two types of C/EBPα mutations play distinct but collaborative roles in leukemogenesis: lessons from clinical data and BMT models.
Kato N; Kitaura J; Doki N; Komeno Y; Watanabe-Okochi N; Togami K; Nakahara F; Oki T; Enomoto Y; Fukuchi Y; Nakajima H; Harada Y; Harada H; Kitamura T
Blood; 2011 Jan; 117(1):221-33. PubMed ID: 20884804
[TBL] [Abstract][Full Text] [Related]
5. Sox4 is a key oncogenic target in C/EBPα mutant acute myeloid leukemia.
Zhang H; Alberich-Jorda M; Amabile G; Yang H; Staber PB; Di Ruscio A; Welner RS; Ebralidze A; Zhang J; Levantini E; Lefebvre V; Valk PJ; Delwel R; Hoogenkamp M; Nerlov C; Cammenga J; Saez B; Scadden DT; Bonifer C; Ye M; Tenen DG
Cancer Cell; 2013 Nov; 24(5):575-88. PubMed ID: 24183681
[TBL] [Abstract][Full Text] [Related]
6. C/EBPα regulated microRNA-34a targets E2F3 during granulopoiesis and is down-regulated in AML with CEBPA mutations.
Pulikkan JA; Peramangalam PS; Dengler V; Ho PA; Preudhomme C; Meshinchi S; Christopeit M; Nibourel O; Müller-Tidow C; Bohlander SK; Tenen DG; Behre G
Blood; 2010 Dec; 116(25):5638-49. PubMed ID: 20889924
[TBL] [Abstract][Full Text] [Related]
7. C/EBPα transcription factor is regulated by the RANK cytoplasmic
Jules J; Chen W; Feng X; Li YP
J Biol Chem; 2018 Jan; 293(4):1480-1492. PubMed ID: 29122885
[TBL] [Abstract][Full Text] [Related]
8. Lenalidomide-mediated enhanced translation of C/EBPα-p30 protein up-regulates expression of the antileukemic microRNA-181a in acute myeloid leukemia.
Hickey CJ; Schwind S; Radomska HS; Dorrance AM; Santhanam R; Mishra A; Wu YZ; Alachkar H; Maharry K; Nicolet D; Mrózek K; Walker A; Eiring AM; Whitman SP; Becker H; Perrotti D; Wu LC; Zhao X; Fehniger TA; Vij R; Byrd JC; Blum W; Lee LJ; Caligiuri MA; Bloomfield CD; Garzon R; Marcucci G
Blood; 2013 Jan; 121(1):159-69. PubMed ID: 23100311
[TBL] [Abstract][Full Text] [Related]
9.
Liu M; Du M; Yu J; Qian Z; Gao Y; Pan W; Zhao X; Wang M; Li H; Zheng J; Huang Q; Wang LM; Xiao H
Oncoimmunology; 2022; 11(1):2016158. PubMed ID: 35003895
[TBL] [Abstract][Full Text] [Related]
10. C/EBPα overrides epigenetic reprogramming by oncogenic transcription factors in acute myeloid leukemia.
Loke J; Chin PS; Keane P; Pickin A; Assi SA; Ptasinska A; Imperato MR; Cockerill PN; Bonifer C
Blood Adv; 2018 Feb; 2(3):271-284. PubMed ID: 29431622
[TBL] [Abstract][Full Text] [Related]
11. C/EBPα and MYB regulate FLT3 expression in AML.
Volpe G; Walton DS; Del Pozzo W; Garcia P; Dassé E; O'Neill LP; Griffiths M; Frampton J; Dumon S
Leukemia; 2013 Jul; 27(7):1487-96. PubMed ID: 23340802
[TBL] [Abstract][Full Text] [Related]
12. Expression and regulation of C/EBPα in normal myelopoiesis and in malignant transformation.
Avellino R; Delwel R
Blood; 2017 Apr; 129(15):2083-2091. PubMed ID: 28179278
[TBL] [Abstract][Full Text] [Related]
13. C/EBPα in normal and malignant myelopoiesis.
Friedman AD
Int J Hematol; 2015 Apr; 101(4):330-41. PubMed ID: 25753223
[TBL] [Abstract][Full Text] [Related]
14. Target proteins of C/EBPalphap30 in AML: C/EBPalphap30 enhances sumoylation of C/EBPalphap42 via up-regulation of Ubc9.
Geletu M; Balkhi MY; Peer Zada AA; Christopeit M; Pulikkan JA; Trivedi AK; Tenen DG; Behre G
Blood; 2007 Nov; 110(9):3301-9. PubMed ID: 17671234
[TBL] [Abstract][Full Text] [Related]
15. C/EBPalpha directs monocytic commitment of primary myeloid progenitors.
Wang D; D'Costa J; Civin CI; Friedman AD
Blood; 2006 Aug; 108(4):1223-9. PubMed ID: 16645168
[TBL] [Abstract][Full Text] [Related]
16. Regulation of Trib2 by an E2F1-C/EBPα feedback loop in AML cell proliferation.
Rishi L; Hannon M; Salomè M; Hasemann M; Frank AK; Campos J; Timoney J; O'Connor C; Cahill MR; Porse B; Keeshan K
Blood; 2014 Apr; 123(15):2389-400. PubMed ID: 24516045
[TBL] [Abstract][Full Text] [Related]
17. Elevated PIN1 expression by C/EBPalpha-p30 blocks C/EBPalpha-induced granulocytic differentiation through c-Jun in AML.
Pulikkan JA; Dengler V; Peer Zada AA; Kawasaki A; Geletu M; Pasalic Z; Bohlander SK; Ryo A; Tenen DG; Behre G
Leukemia; 2010 May; 24(5):914-23. PubMed ID: 20376080
[TBL] [Abstract][Full Text] [Related]
18. A C-terminal mutant of CCAAT-enhancer-binding protein α (C/EBPα-Cm) downregulates Csf1r, a potent accelerator in the progression of acute myeloid leukemia with C/EBPα-Cm.
Togami K; Kitaura J; Uchida T; Inoue D; Nishimura K; Kawabata KC; Nagase R; Horikawa S; Izawa K; Fukuyama T; Nakahara F; Oki T; Harada Y; Harada H; Aburatani H; Kitamura T
Exp Hematol; 2015 Apr; 43(4):300-8.e1. PubMed ID: 25534203
[TBL] [Abstract][Full Text] [Related]
19. Post-transcriptional modulation of C/EBPα prompts monocytic differentiation and apoptosis in acute myelomonocytic leukaemia cells.
Yoshida H; Imamura T; Fujiki A; Hirashima Y; Miyachi M; Inukai T; Hosoi H
Leuk Res; 2012 Jun; 36(6):735-41. PubMed ID: 22349414
[TBL] [Abstract][Full Text] [Related]
20. Functional interaction of CCAAT/enhancer-binding-protein-α basic region mutants with E2F transcription factors and DNA.
Kowenz-Leutz E; Schuetz A; Liu Q; Knoblich M; Heinemann U; Leutz A
Biochim Biophys Acta; 2016 Jul; 1859(7):841-7. PubMed ID: 27131901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
